{
    "clinical_study": {
        "@rank": "132801", 
        "brief_summary": {
            "textblock": "Evaluation of immunological reconstitution after haploidentical BMT using a nonmyeloablative\n      preparative regimen and post-transplant cyclophosphamide in patients with poor prognosis\n      lymphoma"
        }, 
        "brief_title": "Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Lymphoma", 
        "condition_browse": {
            "mesh_term": "Lymphoma"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with lymphoma (any histology) relapsed after high dose chemotherapy and in\n             partial remission, complete remission or stable disease after the last CT line that\n\n          -  Signed informed consent to perform an haploidentical allo-BMT using a\n             nonmyeloablative preparative regimen and post-transplant cyclophosphamide\n\n        Exclusion Criteria:\n\n        none"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with lymphoma (any histology)"
            }
        }, 
        "enrollment": {
            "#text": "23", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01891578", 
            "org_study_id": "ONC/OSS-04/2010"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 28, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rozzano", 
                    "country": "Italy", 
                    "state": "MI", 
                    "zip": "20089"
                }, 
                "name": "Istituto Clinico Humanitas"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "1", 
        "official_title": "Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation Using a Nonmyeloablative Preparative Regimen and Post-transplant Cyclophosphamide, in Patients With Poor Prognosis Lymphomas", 
        "overall_official": {
            "affiliation": "Istituto Clinico Humanitas", 
            "last_name": "Armando Santoro, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Evaluation of  T lymphocytes and NK cells absolute number", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01891578"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Istituto Clinico Humanitas", 
            "investigator_full_name": "Armando Santoro, MD", 
            "investigator_title": "MD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Evaluation, by flow cytometry, of discrete T cell populations, including CD4+ and CD8+ TN, TSCM, TCM and TEM, NK and NKT cells, B cells, dendritic cell subsets", 
                "measure": "Evaluation of discrete T-cells populations", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Evaluation of antigen-specific T cell frequency towards CMV, EBV and influenza virus by MHC tetramers", 
                "measure": "Evaluation of antigen-specific T cell populations", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "antigen-specific T lymphocyte's functionality towards tumor cell line evaluated using a degranulation assay", 
                "measure": "Evaluation of antigen-specific T lymphocyte's functionality", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Evaluation of cytokines production by IL-2 and anti-CD16 activated NK cells", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "Istituto Clinico Humanitas", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Armando Santoro, MD", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2013"
    }
}